3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
32
Metastatic Castration-resistant Prostate Cancer
4
Kidney Neoplasms
3
Prostatic Neoplasms, Castration-Resistant
2
Carcinoma, Renal Cell
2
Urogenital Neoplasms
1
Thrombocytopenia
1
Renal Insufficiency
1
Prostatic Diseases
1
Prostate Cancer Metastatic
1
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
1
Neoplasms by Site
1
Neoplasms
1
Metastatic Hormone Naive Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer (mCRPC)
1
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
1
Male Urogenital Diseases
1
Liver Neoplasms
1
High-Risk Localized Prostate Cancer
1
Glioma
1
Glioblastoma
1
Genital Neoplasms, Male
1
Disease
1
Cytopenia
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Astrocytoma
1
Anemia
1
Interventions
Blood Specimen Collection
5
pembrolizumab
2
fluciclovine F-18
2
Surveys and Questionnaires
2
Preoperative Exercise
2
Magnetic Resonance Imaging
2
Exercise
2
Cryosurgery
2
Bevacizumab
2
tislelizumab
1
neratinib
1
imetelstat
1
daratumumab
1
atezolizumab
1
abiraterone
1
Waiting Lists
1
Videotape Recording
1
Urine Specimen Collection
1
Transcutaneous Electric Nerve Stimulation
1
Tomography, X-Ray Computed
1
Thoracic Surgical Procedures
1
TIC10 compound
1
Sulfonylurea Compounds
1
Standard of Care
1
Specimen Handling
1
Sodium-Glucose Transporter 2 Inhibitors
1
Serologic Tests
1
Sequence Analysis, RNA
1
S-Adenosylmethionine
1
Referral and Consultation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Pluvicto
×
1 year
×
Clear all
NCT07054346
2026-04-01
LUTACT
University of California, San Francisco
Phase 1
Recruiting
45 enrolled